Method for the diagnosis and prognosis of malignant diseases
First Claim
Patent Images
1. A method of treating cancer in a mammal comprising administering to said mammal a therapeutically effective amount of an anti-nucleolin agent and a pharmaceutically acceptable carrier;
- wherein the anti-nucleolin agent comprises a nucleolin monoclonal antibody.
2 Assignments
0 Petitions
Accused Products
Abstract
Methods for the treatment of tumors and cancer by exploiting the surface expression of the usually nuclear-localized protein, nucleolin.
52 Citations
21 Claims
-
1. A method of treating cancer in a mammal comprising administering to said mammal a therapeutically effective amount of an anti-nucleolin agent and a pharmaceutically acceptable carrier;
wherein the anti-nucleolin agent comprises a nucleolin monoclonal antibody. - View Dependent Claims (2, 3, 4, 12, 13, 18)
- 5. A method of treating cancer in a human, comprising administering to said human a therapeutically effective amount of an anti-nucleolin monoclonal antibody and a pharmaceutically acceptable carrier, wherein said nucleolin antibody is substantially non-immunogenic to human.
- 9. A method of treating cancer in a mammal comprising administering to said mammal a therapeutically effective amount of an anti-nucleolin monoclonal antibody, a chemotoxic or chemotherapeutic agent and a pharmaceutically acceptable carrier.
- 11. A method of treating cancer in a mammal comprising administering to said mammal a therapeutically effective amount of an anti-nucleolin monoclonal antibody and a pharmaceutically acceptable carrier, and further treating said mammal with radiation therapy.
Specification